Advised best practice for the use of emollients in eczema and other dry skin conditions

Journal of Dermatological Treatment

Volumn 13, Issue 3, 2002, Pages 103-106

  Holden, C ^a,b   English, J ^c   Hoare, C ^d   Jordan, A ^e   Kownacki, S ^f,g   Turnbull, R ^h   Staughton, RCD ^h  

^a ST HELIER HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d NATIONAL ECZEMA SOCIETY   (United Kingdom)

^e BUCKINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^f NATIONAL HEALTH SERVICE   (United Kingdom)

^g NORTHAMPTON GENERAL HOSPITAL NHS TRUST   (United Kingdom)

^h CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Dry skin; Eczema; Emollients

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT;

CLINICAL PRACTICE; DRY SKIN; ECZEMA; HEALTH PROGRAM; HUMAN; LONG TERM CARE; MEDICAL SOCIETY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SAFETY; SELF CARE; UNITED KINGDOM;

ECZEMA; EMOLLIENTS; HUMANS; SKIN DISEASES;

EID: 0036736853     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630260199442     Document Type: Review

References (20)

1. Wertz PW, Lipids and barrier function of the skin. Acta Derm Venereol (2000) 208 (suppl): 7-11.
2. Elias PM, Wood LC, Feingold KR, Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat (1999) 10(3): 119-26.
3. Cork MJ, The importance of skin barrier function. J Dermatol Treat (1997) 8: S7-13.
4. Werfel T, Kapp A, Environmental and other major provocation factors in atopic dermatitis. Allergy (1998) 53(8): 731-9.
5. Williams HC, Atopic eczema. We should look to the environment. BMJ (1995) 311: 1241-2.
6. Tupker RA, Willis C, Berardesca E et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis (1997) 37: 53-69.
7. Denda M, Influence of dry environment on epidermal function. J Dermatol Sci (2000) 24 (suppl 1): S22-8.
8. Hara J, Higuchi K, Okamoto R et al, High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol (2000) 115(3): 406-13.
9. Imokawa G, Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol (2001) 45 (suppl 1): S29-32.
10. Chamlin SL, Frieden IJ, Fowler A et al, Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol (2001) 137: 1110-12.
11. Loden M, Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products. Acta Derm Venereol Suppl (Stockh) (1995) 192: 1-48.
12. Agner T, Held E, West W et al, Evaluation of an experimental patch test model for the detection of irritant skin reactions to moisturisers. Skin Res Technol (2000) 6(4): 250-4.
13. Hoare C, Li Wan Po A, Williams H, Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4(37): 1-191.
14. Clark C, Hoare C, Making the most of emollients. Pharmaceutical J (2001) 266: 227-9.
15. McHenry PM, Williams HC, Bingham EA, Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. BMJ (1995) 310: 843-7.
16. Lucky AW, Leach AD, Laskarzewski P, Wenck H, Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol (1997) 14: 321-4.
17. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G, Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol (1999) 40: 882-6.
18. Cork MJ, Complete emollient therapy. The National Association of Fundholding Practices year book. Scorpio: London, 1998.
19. Monthly Index of Medical Specialities (MIMS). Haymarket: London, March 2002, p. 278.
20. Dermatological Care Working Group, Assessment of best practice for dermatology services in primary care. Ash Communications Healthcare: London, April 2001.